Significant differences in CVD risk factors between men and women with type 2 diabetes

©2014 Mary Ann Liebert, Inc., publishers

Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease (CVD). A new study showing that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women is published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

Joni Strom Williams, MD, MPH and coauthors from Medical University of South Carolina and Ralph H. Johnson VA Medical Center (Charleston, SC), compared three individual CVD risk factors and a "composite control" factor (comprised of all three risk factors together) among a group of men and women with type 2 diabetes. In the article "Gender Differences in Composite Control of Cardiovascular Risk Factors Among Patients with Type 2 Diabetes" the authors report significant disparities for blood pressure, low-density lipoprotein (LDL) cholesterol, and composite control, but not for control of glycosylated hemoglobin A1c.

"Cardiovascular disease continues to be a significant factor for increased morbidity and mortality in people with type 2 diabetes," says DTT Editor-in-Chief Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver. "Every attempt should be made to reduce gender differences as they relate to co-morbidities."

More information: The article is available free on the DTT website at http://www.liebertpub.com/dtt.

add to favorites email to friend print save as pdf

Related Stories

Interarm BP difference may up cardiac risk in diabetes

Apr 03, 2014

(HealthDay)—Interarm differences in systolic blood pressure (BP) in patients with diabetes may be associated with an increased risk of cardiovascular morbidity and mortality, according to research published ...

Recommended for you

Use of drug-eluting stents may cut in-hospital mortality

Nov 20, 2014

(HealthDay)—Use of drug-eluting stents (DES) rather than bare-metal stents (BMS) for percutaneous coronary intervention (PCI) is associated with lower rates of in-hospital mortality, according to research ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.